Inovio Pharmaceuticals (INO): Cramer said this speculative biotech can be bought, but only if investors understand the risks.
Analyst Scot Ciccarelli sees positive momentum even in a tough environment.
Healthcare leads markets after the release of the Senate health plan.
Healthcare stocks led markets higher after a shaky morning following the release of the Senate Republicans' healthcare plan.
Healthcare leads markets after Senate bill's release.